News

HomebyHemp: Lund’s healthiest Attefallshus!

Homebyhemp AB will offer environmentally friendly, durable, turnkey module housing as well as wall panels and insulation composed of the bio-composite material, hempcrete. The composition of Hempcrete (the inner woody core of the hemp plant, lime and water) gives the material its unique hygroscopic properties. The purpose is to meet

Read more »

Atomic layer etching for nano device fabrication

Our way of living today would not be possible without modern electronic devices. Current information and communication technologies, industry, medicine and biotechnology development are made possible by the huge development of semiconductor electronics technology, based on a long-term trend of continuous miniaturization. This ALE-based method of manufacturing nanostructures with a

Read more »

Histone 1.3 – a new and unique biomarker for pancreatic cancer

Pancreatic cancer is one of the most serious forms of cancer. The difficulty is to identify pancreatic cancer “early”. There are no biomarkers in either blood or tissue to provide diagnosis, prognostic / predictive help and support in selecting therapy. Research has now found a pancreatic cancer-specific marker (Histone 1.3;

Read more »

Treatment of malignant brain tumours by complementation

Glioblastoma is the most common primary brain tumour in humans. It is a diagnosis with a very bleak outcome. The goal is to analyse whether glioblastoma expresses C1-IA and CRP (proteins) that inhibit immune response by inactivating the complement system, and to test treatment in various animal models for glioblastoma.

Read more »

A new drug to cure Mucopolysaccharidosis

Mucopolysaccharide Type I (MPS-I) belongs to the wider group of lysosomal storage disorders. The most serious form is Hurler’s syndrome. None of the available interventions for MPS-I modify central nervous system pathology, while the proposed drug reaches CNS. The subject is not yet an approved drug, but it is now

Read more »

Development of new antidiabetic treatment

Type 1 diabetes (T1D) is an autoimmune disease where activation of the immune system causes the cells in the pancreas that produce insulin to be destroyed. The project aims to develop a drug that can significantly reduce the risk of hypo / hyperglycaemia and sequelae; a peptide drug that will

Read more »